Monopar Therapeutics (MNPR)
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Address
1000 SKOKIE BLVD SUITE 350
WILMETTE, IL 60091
Founded
2014
Number of Employees
10
Website
http://www.monopartx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)